on july 20, 2023, the united kingdom issued the cosmetic products (restriction of chemical substances) regulations 2023 (no. 836 of 2023), to revise the requirements for the use of methyl-n-methylanthranilate (cas no. 85-91-6), haa, and haa (nano) (cas no. 919803-06-8). this regulation applies to england, wales, and scotland.
amendment to annex 3 (it comes into force on 6th july 2024
chemical name/inn | name of common ingredients glossory | cas number | ec number | product type, body parts | maximum concentration in ready for use preparation | other |
methyl-n-methylanthranilate
|
| 85-91-6 | 201-642-6 | (a) leave-on products (b) rinse-off products | 0.1% 0.2% | for leave on products only: not to be used in sunscreen products and products marketed for exposure to natural or artificial uv light. for leave-on and rinse-off products: do not use with nitrosating agents; maximum nitrosamine content: 50μg/kg; keep in nitrite-free containers.” |
a cosmetic product that is placed on the market prior to 6th july 2024 can continue to be made available on the market until 6th july 2026.
amendment to annex 6 (it comes into force on 10th august 2024)
chemical name/inn | name of common ingredients glossory | cas number | ec number | product type, body parts | maximum concentration in ready for use preparation | other |
1,1’-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone | bis-(diethylaminohydroxybenzoyl benzoyl) piperazine
| 919803-06-8 | 485-100-6 |
| 10% | in case of combined use of bis-(diethylaminohydroxybenzoyl benzoyl) piperazine and bis-(diethylaminohydroxybenzoyl benzoyl) piperazine (nano), the sum shall not exceed 10%. |
1,1’-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone | bis-(diethylaminohydroxybenzoyl benzoyl) piperazine (nano)
| 919803-06-8 | 485-100-6 |
| 10% | only nanomaterials having the following characteristics are allowed: -purity ≥ 97%, -median particle size d50 (50% of the number below this diameter): ≥ 50nm of number size distribution. not to be used in applications that may lead to exposure of the end user’s lungs by inhalation. in case of combined use of bis-(diethylaminohydroxybenzoyl benzoyl) piperazine and bis-(diethylaminohydroxybenzoyl benzoyl) piperazine (nano), the sum shall not exceed 10%. ” |
if you need any assistance or have any questions, please get in touch with us at .
contact us
quick navigation